Physician profile
Susan E Ring
NPI 1790708667
$2,074.01
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $413 · 2021: $661.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $691.01 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $395.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.79 | 2019-2020 | |
| Amgen INC. | $155.10 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $128.54 | 2019 | |
| Tactile Systems Technology INC | $104.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $76.38 | 2020-2021 | |
| Amarin Pharma, INC. | $71.00 | 2020-2021 | |
| Novo Nordisk INC | $33.95 | 2019-2020 | |
| Mylan Specialty L.P. | $32.42 | 2020-2021 | |
| Glaxosmithkline, LLC. | $31.02 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $28.03 | 2021 | |
| Stimwave Technologies Incorporated | $21.09 | 2019 | |
| Genzyme Corporation | $16.77 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.31 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $14.03 | 2019 | |
| Esperion Therapeutics, INC. | $12.22 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.99 | 2020 | |
| Astellas Pharma US INC | $11.97 | 2019 | |
| Lilly USA, LLC | $11.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.53 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.